MIAMI, FL. JUNE 6, 2018 — ArisGlobal, LLC, a leading provider of integrated cloud-based software solutions for life sciences, will present two Innovation Theater sessions at the DIA 2018 Annual Global Meeting to be held in Boston, MA from June 24-28, 2018. Both 30-minute sessions present related information on the value that the ArisGlobal LifeSphere® cognitive, cross-domain platform can bring to transforming pharma with a process-driven approach and industry standard practices, with one session focused on clinical development and the other on regulatory affairs.
“Our thirty-plus years of life sciences experience in working with pharmas, CROs and medical device companies of all sizes has culminated in ArisGlobal LifeSphere® as an innovative, cognitive platform where its advanced technology is now a true enabler,” said Manish Varma, Chief Strategy Officer, ArisGlobal. “These sessions will show how LifeSphere enables an enterprise-level approach that unifies every facet of the product lifecycle, ensuring that the digital journey is cohesive, streamlined, agile and responsive across systems, regions, and geographies.”
The first session, “A Clinical Perspective: How Cognitive E-2-E Platforms can Transform Productivity in Pharma” is scheduled for Monday, June 25 at 4:45 p.m. in Innovation Theater 2, located in the main exhibit hall. Presented by Vitthal Gouri, ArisGlobal’s Director of Clinical Solutions, attendees will learn how, despite GMP, GCP, GVP and Good Regulatory Practice, inconsistent data provisioning has resulted in ‘silo thinking’ across departments, which has led to disconnected platforms involving their own standards and weak data governance.
The second session, “A Regulatory Perspective: How Cognitive E-2-E Pharma Platforms can Transform Productivity in Pharma” is scheduled for Wednesday, June 27 at 9:45 a.m. in Innovation Theater 1. In this session, David Scanlon, ArisGlobal’s Senior Director of Regulatory Strategy, will give attendees a Regulatory perspective on how the recent emphasis on data exchange to enhance patient protection has similarly exposed disconnected platforms with weak standards and data governance.
David and Vitthal will explore how clinical and regulatory can seamlessly integrate processes. Their sessions, while on different days, will tie together the flow of E-2-E processes from the Clinical Trials process through Regulatory Operations within an integrated platform: LifeSphere. Attendees are encouraged to attend both sessions to get the full picture.
ArisGlobal is an exhibitor and will be showcasing ArisGlobal LifeSphere, its cognitive computing platform, in Booth #1710. Attendees are invited to meet with ArisGlobal staff to learn about its innovative and leading pharmacovigilance and safety platform.
ArisGlobal is transforming the way today’s most successful Life Sciences companies develop breakthroughs and bring new products to market. Our end-to-end drug development technology platform, LifeSphere®, integrates our proprietary Nava® cognitive computing engine to automate all core functions of the drug development lifecycle. Designed with deep expertise and a long-term perspective that spans more than 30 years, LifeSphere® is a unified platform that boosts efficiency, ensures compliance, delivers actionable insights, and lowers total cost of ownership through multi-tenant SaaS architecture.